Shanghai Pharmaceuticals Holding Co Ltd (601607) — Cash Flow Reinvestment Rate
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Cash Flow Reinvestment Rate of 0.31x as of September 2025, reinvesting CN¥487.63 Million (capex CN¥487.63 Million ) from operating cash flow of CN¥1.56 Billion. See Shanghai Pharmaceuticals Holding Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Shanghai Pharmaceuticals Holding Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see 601607 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Shanghai Pharmaceuticals Holding Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Shanghai Pharmaceuticals Holding Co Ltd. See 601607 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.60x | CN¥3.72 Billion | CN¥6.15 Billion | CN¥2.33 Billion | ▼ -37.4% |
| 2024 | 0.97x | CN¥5.62 Billion | CN¥5.83 Billion | CN¥2.40 Billion | ▼ -7.6% |
| 2023 | 1.04x | CN¥5.46 Billion | CN¥5.23 Billion | CN¥2.97 Billion | ▼ -67.3% |
| 2022 | 3.20x | CN¥15.16 Billion | CN¥4.74 Billion | CN¥2.68 Billion | ▲ +284.6% |
| 2021 | 0.83x | CN¥4.21 Billion | CN¥5.06 Billion | CN¥4.12 Billion | ▲ +49.0% |
| 2020 | 0.56x | CN¥3.82 Billion | CN¥6.84 Billion | CN¥3.01 Billion | ▼ -36.3% |
| 2019 | 0.88x | CN¥5.28 Billion | CN¥6.02 Billion | CN¥2.75 Billion | ▲ +6.1% |
| 2018 | 0.83x | CN¥2.59 Billion | CN¥3.14 Billion | CN¥1.94 Billion | ▼ -2.0% |
| 2017 | 0.84x | CN¥2.23 Billion | CN¥2.65 Billion | CN¥2.01 Billion | ▼ -67.3% |
| 2016 | 2.57x | CN¥5.01 Billion | CN¥1.95 Billion | CN¥2.12 Billion | ▲ +78.6% |
| 2015 | 1.44x | CN¥1.94 Billion | CN¥1.35 Billion | CN¥1.72 Billion | ▲ +49.0% |
| 2014 | 0.97x | CN¥1.29 Billion | CN¥1.34 Billion | CN¥1.29 Billion | ▲ +4.0% |
| 2013 | 0.93x | CN¥905.06 Million | CN¥973.45 Million | CN¥905.06 Million | ▲ +50.9% |
| 2012 | 0.62x | CN¥708.91 Million | CN¥1.15 Billion | CN¥708.91 Million | ▲ +164.0% |
| 2011 | 0.23x | CN¥413.54 Million | CN¥1.77 Billion | CN¥413.54 Million | ▼ -28.5% |
| 2010 | 0.33x | CN¥550.30 Million | CN¥1.69 Billion | CN¥550.30 Million | ▲ +171.1% |
| 2009 | 0.12x | CN¥79.97 Million | CN¥664.13 Million | CN¥79.97 Million | ▼ -62.0% |
| 2008 | 0.32x | CN¥90.50 Million | CN¥285.68 Million | CN¥90.50 Million | ▼ -19.4% |
| 2007 | 0.39x | CN¥192.29 Million | CN¥488.94 Million | CN¥192.29 Million | ▲ +51.3% |
| 2006 | 0.26x | CN¥151.60 Million | CN¥583.11 Million | CN¥151.60 Million | ▼ -90.4% |
| 2005 | 2.71x | CN¥198.09 Million | CN¥73.00 Million | CN¥198.09 Million | ▼ -34.2% |
| 2004 | 4.13x | CN¥254.38 Million | CN¥61.66 Million | CN¥254.38 Million | ▼ -98.8% |
| 2003 | 350.18x | CN¥169.58 Million | CN¥484.27K | CN¥169.58 Million | ▲ +12537.3% |
| 2002 | 2.77x | CN¥279.44 Million | CN¥100.84 Million | CN¥279.44 Million | ▲ +25.9% |
| 2001 | 2.20x | CN¥144.71 Million | CN¥65.73 Million | CN¥144.71 Million | ▲ +128.2% |
| 2000 | 0.96x | CN¥141.09 Million | CN¥146.22 Million | CN¥141.09 Million | ▲ +202.8% |
| 1999 | 0.32x | CN¥52.48 Million | CN¥164.67 Million | CN¥52.48 Million | — |